Global Pharmaceuticals & Biotech Big Green Snowflakes

Danaher

Market Cap: US$137.9b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

TransCode Therapeutics

Market Cap: US$8.9m

A biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.

Cyclacel Pharmaceuticals

Market Cap: US$15.2m

A clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.

Veru

Market Cap: US$56.6m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Nuvation Bio

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Citius Oncology

Market Cap: US$146.6m

Focuses on the development and commercialization of innovative targeted oncology therapies.

Caribou Biosciences

Market Cap: US$165.8m

A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.

Devonian Health Group

Market Cap: CA$27.9m

Engages in the development of botanical drugs.

Revelation Biosciences

Market Cap: US$4.2m

Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.

Syndax Pharmaceuticals

Market Cap: US$1.4b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

AN2 Therapeutics

Market Cap: US$33.6m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

Beam Therapeutics

Market Cap: US$2.0b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Clearmind Medicine

Market Cap: US$5.3m

A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.

Polyrizon

Market Cap: US$10.8m

A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.

PDS Biotechnology

Market Cap: US$57.8m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

Entera Bio

Market Cap: US$84.9m

A clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs.

Alaunos Therapeutics

Market Cap: US$4.8m

A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.

Malin

Market Cap: €34.4m

Through its subsidiaries, operates in the life sciences industry in Ireland and the United States.

GlaxoSmithKlineE

Market Cap: ج.م5.7b

Engages in production of pharmaceutical chemicals.

Silence Therapeutics

Market Cap: US$245.9m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Septerna

Market Cap: US$678.6m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Barinthus Biotherapeutics

Market Cap: US$46.8m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

Astria Therapeutics

Market Cap: US$425.0m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Entheon Biomedical

Market Cap: CA$1.4m

Operates as a biotechnology research and development company.

Orient Pharma

Market Cap: NT$5.7b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

Ben Tre Pharmaceutical

Market Cap: ₫248.4b

Manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally.

Parataxis Korea

Market Cap: ₩170.6b

A clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide.

Johnson Chemical Pharmaceutical Works

Market Cap: NT$3.2b

Johnson Chemical Pharmaceutical Works Co., Ltd.

Shouyao Holdings (Beijing)

Market Cap: CN¥6.5b

Engages in the research, development, and production of pharmaceutical drugs in China.

Phaarmasia

Market Cap: ₹239.8m

Manufactures and sells oral contraceptive pills and iron tablets in India.

BIOBIJOULtd

Market Cap: ₩253.5b

Engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea.

LanZhou Foci PharmaceuticalLtd

Market Cap: CN¥4.7b

Research and development, production, and sales of traditional chinese medicines and health products in China.

Liven Pharmaceuticals

Market Cap: PK₨6.1b

Manufactures and markets pharmaceutical products in Pakistan.

Ascentage Pharma Group International

Market Cap: HK$28.5b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

PCI Biotech Holding

Market Cap: NOK 15.1m

A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.

Ginwa Enterprise (Group)

Market Cap: CN¥2.6b

Researches, develops, produces, and sells pharmaceuticals in China.